Mycotoxin exposure presents a complex and often underrecognized challenge in clinical practice, with far-reaching effects on detoxification capacity, immune regulation, and neurological function. These secondary metabolites produced by molds can disrupt key biotransformation pathways, impair mitochondrial function, and promote oxidative stress and neuroinflammation, ultimately diminishing the body’s ability to effectively clear toxic burden. As a result, targeted nutritional strategies aimed at supporting detoxification pathways, cellular health, and protecting brain health have become an important component of a comprehensive, systems-based approach to care.
Mycotoxins inhibit protein synthesis and mitochondrial function, induce oxidative stress, damage DNA and RNA, cause apoptosis/necrosis, and cell cycle arrest. Mycotoxins have carcinogenic, teratogenic, hepatotoxic, neurotoxic, and immunotoxic properties.1,2 Treatment strategies should be aimed at supporting healthy cellular function and host defense against toxicity, neuroprotection, and correcting oxidative tissue damage.
Mycotoxins and Detoxification
Like most environmental toxins, mycotoxins are processed and eliminated via the liver’s phase I cytochrome P450 enzymes and phase II (sulfation, glucuronidation, glutathione conjugation, etc.) detoxification pathways. These enzymes and pathways require multiple vitamins, minerals, and other nutrients as cofactors. The body also relies on gut microbiota to transform mycotoxins into less toxic metabolites.1,3-5 Many mycotoxins are eliminated via biliary and thus fecal excretion.
Health effects differ depending on the specific mycotoxin and are influenced by both the amount and length of exposure. Individual factors such as age, gender, physiology, genetics, epigenetics, other environmental exposures, and even microbiome health can significantly influence the toxicokinetic properties of mycotoxins.4,6
There are several ways that mycotoxins can override the host’s defense mechanisms and even be shielded from elimination:
- They suppress the innate and adaptive immune systems, decreasing the body’s resistance to infectious disease.2,7
- Binding kinetics to blood proteins as in the case with ochratoxin A and albumin prevents elimination.
- Mycotoxins can be recycled via entero-hepatic recirculation.1
- Mycotoxins can cause dysbiosis of gut microflora, which may result in reuptake of mycotoxins.1,5
- Toxins and lack of nutrient cofactors influence biochemical enzymes’ ability to perform their normal functions.8
Step One: Minimize Mold Exposure
The first and most critical step in addressing mycotoxin-related illness is identifying and minimizing exposure to the source of mold. Without removing or reducing ongoing contact, even the most advanced treatments are unlikely to be effective, as the body continues to be burdened by incoming toxins. This process often involves careful inspection of living and working environments for hidden water damage, musty odors, or visible mold growth, and may require professional assessment or remediation. By prioritizing source control at the outset, individuals create the necessary foundation for recovery, allowing the body’s natural detoxification and healing processes to function more effectively.
Illness from mycotoxin ingestion alone is relatively uncommon. Yet many clinical protocols emphasize dietary restriction of foods that may contain mycotoxins, which may address only a small part of the overall exposure picture. In many cases, the primary source is ongoing inhaled exposure to molds in water-damaged buildings. Foodborne mycotoxins are relevant in select situations and tend not to be an issue in developed countries with adequate food regulations.
Step Two: 8 Key Supplements for Mycotoxin Exposure
A solid supplement protocol can optimize the body’s natural detoxification processes and expedite a patient’s recovery from mycotoxin illness. Since many patients with mycotoxin illness struggle with neurological consequences, supplements that help support brain health can address common symptoms like brain fog, confusion, memory loss, sleep disruption, anxiety, depression, and mood swings. Supplements may also help repair the immune system, support the body’s cellular function and metabolic processes, and reverse oxidative cellular and tissue damage.
1. Melatonin
Melatonin, the well-known sleep hormone, exhibits a wide range of biological functions. Melatonin regulates metabolism, circadian rhythm, and immune function, and has antioxidant, anti-aging, anti-tumor, and neuroprotective effects.9 Because of these properties, melatonin is a good candidate as a protective agent against mycotoxin-induced damage.
Numerous in vitro and animal studies have shown protective effects against several mycotoxins, including ochratoxin A, aflatoxin B1, fumonisins, HT-2, deoxynivalenol, and β-zearalenol.10 Studies on mice showed that melatonin ameliorated ochratoxin-induced liver inflammation, heart and lung damage, oxidative stress, and mitophagy.11,12 Melatonin also benefits the intestinal microbiota and gut barrier function.11
2. B-Complex Vitamins
B vitamins serve multiple roles in biochemistry and healthy tissue function. B vitamins support the body’s natural detoxification processes by acting as essential cofactors for liver enzymes, facilitating the methylation cycle, and synthesizing glutathione. B vitamins are cofactors for mitochondrial ATP/energy production, DNA/RNA synthesis, and neurochemicals.
The importance of all the B vitamins for brain function can be illustrated by the neurological and psychiatric symptoms associated with deficiency. B vitamins support brain health by slowing atrophy and cognitive decline.13 Deficiencies in B12 and folate may contribute to peripheral neuropathy.14 Chronic mycotoxin exposure may contribute to vitamin B12 deficiency by disrupting its role in one-carbon metabolism, potentially leading to impaired methylation and neurological dysfunction.15
3. Magnesium
Magnesium is a necessary cofactor for approximately 300 enzymatic reactions, playing a role in muscle function, energy metabolism, and nervous system function. Magnesium works together with B vitamins for mitochondrial ATP production.16 Because of its cellular demand and the fact that most of the population doesn’t consume enough, magnesium should be part of detoxification and overall health protocols. Supplements containing multiple bioavailable forms of magnesium may better supply the body’s demand.
4. Vitamin D3
Vitamin D has numerous well-known health benefits and may also benefit those with mycotoxin illness. Vitamin D plays a significant role in brain health, cognition, and mood regulation, and supplementation studies have shown reduced depressive symptoms. Vitamin D reduces inflammation and maintains immune balance.17
Chronic exposure to the mycotoxin deoxynivalenol disrupted vitamin D, calcium, and phosphorus balance in pigs. Vitamin D3 supplementation showed a limited benefit under inflammatory stress, suggesting it may support immune-related vitamin D activity.18
5. Vitamin C
Vitamin C is a powerful antioxidant and supports glutathione recycling, reducing oxidative stress. Ascorbic acid is added to many foods as an antioxidant/preservative and is also a mycotoxin-degrading substance.19 The body cannot synthesize vitamin C, making it an essential nutrient. It is well-known for its immune supportive effects, but it’s also important for CNS and neurotransmitter function. Additionally, vitamin C plays a role in analgesia and stress adaptation. Clinical studies using vitamin C show benefit for pain relief, depression, and decreased pro-inflammatory cytokines.20 These critical functions make vitamin C a valuable nutrient for detoxification protocols.
6. Phosphatidylserine
Phosphatidylserine (PS) is a membrane phospholipid required for healthy nerve cell membranes and myelin. Oral PS doses are highly bioavailable in humans and efficiently pass through the blood-brain barrier. It slows or reverses nerve cell deterioration and supports cognition—processes that can be affected by mycotoxins. Multiple clinical studies support doses of 300 mg to 800 mg daily for improved neurological function and mood in Alzheimer’s, chronic depression, and the elderly.21
7. Curcumin
Curcumin, a well-studied constituent of the spice turmeric, has numerous therapeutic indications. It is a potent anti-inflammatory and antioxidant agent and has immunomodulatory effects. Studies have shown improved cognitive function and delayed aging processes. Doses of 90 mg to 1500 mg daily are used in clinical trials for several conditions.22
Animal studies show curcumin’s cytoprotective, anti-inflammatory, and antioxidant activities against mycotoxins aflatoxin, fumonisin B1, deoxynivalenol, and ochratoxin A-induced tissue toxicity.23-26 Additionally, curcumin protects against heavy metal and pathogen-induced toxicity.25 Animal studies also show mitigation of aflatoxin B1 and deoxynivalenol-induced immune suppression.27
8. Probiotics
Probiotics support gut barrier function, microbiome composition, antioxidant activity, and immune system regulation, factors that can be disrupted with mycotoxin and other toxic exposures. Additionally, probiotics, including lactic-acid bacteria, Saccharomyces, and Bacillus species, are effective in removing heavy metals, pesticides, and mycotoxins in vitro and in animal studies.28,29 They can act as biological binders.28
Bacillus species are a group of spore-forming bacteria with robust mycotoxin-degrading potential due to their high growth rate, ability to survive in harsh environments, and diverse metabolic pathways. Bacillus species can transform mycotoxins into less harmful byproducts, act as physical adsorbents or binders, and degrade toxins through enzymatic pathways. Mycotoxin reduction in food and water has been shown in vitro and in animal studies in the agricultural industry.19 Spore-based probiotics have numerous studies supporting efficacy in restoring gut health.
Explore our full library of mycotoxin articles by visiting our Toxic Mold & Mycotoxin Resource Center.
Clinical Evidence and Mycotoxin Treatment Protocols
There are numerous clinical studies supporting these 8 supplements for various health conditions. While there are no clinical studies specifically using these supplements for patients with mycotoxin exposure, their therapeutic action, role as cofactors in biochemistry, and safety profile make them promising adjunctive therapies. Furthermore, many clinicians treating mycotoxin illness using this combination of supplements have had success and even report benefits for healing from other toxic exposures, like metals.
Dr. Andrew Campbell, a mold and mycotoxin specialist, has treated over 20,000 patients with molds/mycotoxins over the last 35 years and published many articles on his experience.
“My approach to treating mycotoxin-related illness includes a combination of different therapies. I’ve found that a 6-month program of research-backed supplements, antifungal medication (such as itraconazole), and sauna can help patients heal from mycotoxin-related illness. It is also important to support the immune system’s reactivity to toxicity by focusing on gut health.”
Dr. Campbell has refined his protocol over 35 years and has suggested doses that are effective in treating mycotoxin-related illness:
|
Recommended Dosing Schedule |
|
| Detox Supplement
Melatonin |
Dosage
3 mg at bedtime |
| B Complex | Potent doses of all the B vitamins once daily |
| Magnesium (succinate, taurinate, malate, citrate complex) | 240 mg twice daily in the morning |
| Vitamin D3 | 5000 IU daily |
| Vitamin C | 1 g three times daily |
| Phospholipid Complex (phosphatidylserine, phosphatidylcholine, phosphatidylethanolamine) | 500 mg daily |
| Curcumin (standardized to 18% curcuminoids) | 500 mg daily |
| Spore-based probiotic | 4-8 billion CFU daily |
Other Supplements and Therapies
You may be able to think of several other substances that support detoxification, mitochondrial health, antioxidant function, and neurological health. Several ideas and protocols exist about how to treat mycotoxins; however, not all are efficacious. The particular combination of supplements mentioned in this article is found to be efficacious by several clinicians.
What About Binders?
Dr. Campbell says that the number one question clinicians ask him when consulting on mycotoxin illness cases is “what about binders?” This one might surprise people, but he says that binders are inefficient for mycotoxins. He explains that mycotoxins are primarily inhaled rather than ingested, limiting the relevance of gastrointestinal binding strategies. Furthermore, the literature suggests that binding capacity is highly variable, with no single agent demonstrating consistent efficacy across the diverse range of mycotoxins.
Binders like clays and activated carbon are used as crop treatments after harvest to reduce mycotoxin levels in food.19 Binders are added to animals and animal feeds to reduce absorption, but the effects are variable.30-32 No human studies show the efficacy of binders in treating mycotoxin-related illness. A major concern with long-term use of binders is nutrient depletion.
Conclusion
Patients and practitioners often begin with minimal, targeted protocols, yet many discover that these nutrients are most effective when used together as part of a comprehensive, synergistic program. Mycotoxin exposure can significantly increase the body’s demand for key nutrients, making broader support both practical and necessary. When thoughtfully combined, these supplements not only aid recovery from mycotoxin-related illness but also help the body respond more effectively to other toxic burdens, including heavy metals, supporting a more complete and resilient healing process.
References
- Kőszegi T, Poór M. Ochratoxin A: Molecular Interactions, Mechanisms of Toxicity and Prevention at the Molecular Level. Toxins. 2016;8(4):111.
- Viljoen M, Claassen N. Pathophysiological aspects of exposure to dampness-associated indoor mould and mycotoxins: A mini-overview. Journal of Hazardous Materials Advances. 2023;9:100228.
- Li P, Su R, Yin R, et al. Detoxification of Mycotoxins through Biotransformation. Toxins. 2020;12(2).
- Cramer B, Visintin L, Maris E, et al. Human biomonitoring of mycotoxins: key challenges and future directions. Mycotoxin research. 2025;42(1):13.
- Li K, Wang S, Qu W, et al. Natural products for Gut-X axis: pharmacology, toxicology and microbiology in mycotoxin-caused diseases. Frontiers in pharmacology. 2024;15:1419844.
- Daschner A. An Evolutionary-Based Framework for Analyzing Mold and Dampness-Associated Symptoms in DMHS. Frontiers in immunology. 2016;7:672.
- Corrier DE. Mycotoxicosis: mechanisms of immunosuppression. Veterinary immunology and immunopathology. 1991;30(1):73-87.
- Zakhari S. Alcohol metabolism and epigenetics changes. Alcohol research : current reviews. 2013;35(1):6-16.
- Luo F, Sandhu AF, Rungratanawanich W, et al. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases. International journal of molecular sciences. 2020;21(19).
- Iranshahy M, Etemad L, Shakeri A, Badibostan H, Karimi G. Protective activity of melatonin against mycotoxins-induced toxicity: A review. Toxicological & Environmental Chemistry. 2019;101(9-10):435-450.
- Ye W, Liu T, Zhang W, Zhang W. The Toxic Mechanism of Gliotoxins and Biosynthetic Strategies for Toxicity Prevention. International journal of molecular sciences. 2021;22(24).
- Okutan H, Aydin G, Ozcelik N. Protective role of melatonin in ochratoxin a toxicity in rat heart and lung. Journal of applied toxicology : JAT. 2004;24(6):505-512.
- Douaud G, Refsum H, de Jager CA, et al. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(23):9523-9528.
- Kennedy DO. B Vitamins and the Brain: Mechanisms, Dose and Efficacy–A Review. Nutrients. 2016;8(2):68.
- Anyanwu EC, Morad M, Campbell AW. Metabolism of mycotoxins, intracellular functions of vitamin B12, and neurological manifestations in patients with chronic toxigenic mold exposures. A review. TheScientificWorldJournal. 2004;4:736-745.
- Gröber U, Schmidt J, Kisters K. Magnesium in Prevention and Therapy. Nutrients. 2015;7(9):8199-8226.
- Grant WB, Wimalawansa SJ, Pludowski P, Cheng RZ. Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines. Nutrients. 2025;17(2).
- Sauvé B, Chorfi Y, Montminy ML, Guay F. Vitamin D Supplementation Impacts Calcium and Phosphorus Metabolism in Piglets Fed a Diet Contaminated with Deoxynivalenol and Challenged with Lipopolysaccharides. Toxins (Basel). 2023;15(6).
- Nguyen T, Chen X, Ma L, Feng Y. Mycotoxin Biodegradation by Bacillus Bacteria-A Review. Toxins (Basel). 2024;16(11).
- Zelfand E. Vitamin C, Pain and Opioid Use Disorder. Integrative medicine (Encinitas, Calif). 2020;19(3):18-29.
- Glade MJ, Smith K. Phosphatidylserine and the human brain. Nutrition (Burbank, Los Angeles County, Calif). 2015;31(6):781-786.
- Nunes YC, Mendes NM, Pereira de Lima E, et al. Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence. Nutrients. 2024;16(16).
- Longobardi C, Damiano S, Andretta E, et al. Curcumin Modulates Nitrosative Stress, Inflammation, and DNA Damage and Protects against Ochratoxin A-Induced Hepatotoxicity and Nephrotoxicity in Rats. Antioxidants (Basel, Switzerland). 2021;10(8).
- Kövesi B, Worlanyo AP, Kulcsár S, et al. Curcumin mitigates ochratoxin A-induced oxidative stress and alters gene expression in broiler chicken liver and kidney. Acta veterinaria Hungarica. 2024;72(1):41-50.
- Dai C, Tian E, Hao Z, et al. Aflatoxin B1 Toxicity and Protective Effects of Curcumin: Molecular Mechanisms and Clinical Implications. Antioxidants (Basel, Switzerland). 2022;11(10).
- Ruan D, Wang WC, Lin CX, et al. Effects of curcumin on performance, antioxidation, intestinal barrier and mitochondrial function in ducks fed corn contaminated with ochratoxin A. Animal : an international journal of animal bioscience. 2019;13(1):42-52.
- Muhmood A, Liu J, Liu D, et al. Mitigation of Deoxynivalenol (DON)- and Aflatoxin B1 (AFB1)-Induced Immune Dysfunction and Apoptosis in Mouse Spleen by Curcumin. Toxins. 2024;16(8).
- Liu L, Xie M, Wei D. Biological Detoxification of Mycotoxins: Current Status and Future Advances. International journal of molecular sciences. 2022;23(3).
- Zarezadeh MP, Saedisomeolia A, Mahmoudinezhad M, M MI, Lu F, Kubow S. Protective Roles of Prebiotics and Probiotics Against Environmental Pollutant-Induced Toxicities: A Systematic Review of Animal Studies. Molecular nutrition & food research. 2026;70(1):e70175.
- Kihal A, Rodríguez-Prado M, Calsamiglia S. The efficacy of mycotoxin binders to control mycotoxins in feeds and the potential risk of interactions with nutrient: a review. Journal of animal science. 2022;100(11).
- Kihal A, Rodríguez-Prado M, Calsamiglia S. A network meta-analysis on the efficacy of different mycotoxin binders to reduce aflatoxin M(1) in milk after aflatoxin B(1) challenge in dairy cows. Journal of dairy science. 2023;106(8):5379-5387.
- Zhu Y, Hassan YI, Lepp D, Shao S, Zhou T. Strategies and Methodologies for Developing Microbial Detoxification Systems to Mitigate Mycotoxins. Toxins. 2017;9(4).
